{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:13:26Z","timestamp":1788344006702,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"DOI":"10.1186\/s40560-026-00924-0","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:34:42Z","timestamp":1785940482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of landiolol and bisoprolol transdermal patch in patients with sepsis-related tachycardia: a retrospective cohort study"],"prefix":"10.1186","volume":"14","author":[{"given":"Shuhei","family":"Murao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fujimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s001340101043","volume":"27","author":"P Reinelt","year":"2001","unstructured":"Reinelt P, Karth GD, Geppert A, Heinz G. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med. 2001;27:1466\u201373. https:\/\/doi.org\/10.1007\/s001340101043.","journal-title":"Intensive Care Med"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49:e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293\u2013316. https:\/\/doi.org\/10.1177\/0885066609340519.","journal-title":"J Intensive Care Med"},{"issue":"81\u20138","key":"924_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.CCM.0000150028.64264.14","volume":"33","author":"O Sander","year":"2005","unstructured":"Sander O, Welters ID, Fo\u00ebx P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33(81\u20138):241\u20132. https:\/\/doi.org\/10.1097\/01.CCM.0000150028.64264.14.","journal-title":"Crit Care Med"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/j.jvca.2019.10.017","volume":"34","author":"A Belletti","year":"2020","unstructured":"Belletti A, Landoni G, Lomivorotov VV, Oriani A, Ajello S. Adrenergic downregulation in critical care: molecular mechanisms and therapeutic evidence. J Cardiothorac Vasc Anesth. 2020;34:1023\u201341. https:\/\/doi.org\/10.1053\/j.jvca.2019.10.017.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683\u201391. https:\/\/doi.org\/10.1001\/jama.2013.278477.","journal-title":"JAMA"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","volume":"8","author":"Y Kakihana","year":"2020","unstructured":"Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 2020;8:863\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(20)30037-0.","journal-title":"Lancet Respir Med"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, Cihl\u00e1\u0159 R, Borgstedt R, Biancofiore G, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50:1622\u201334. https:\/\/doi.org\/10.1007\/s00134-024-07587-1.","journal-title":"Intensive Care Med"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jch.12208","volume":"15","author":"H Matsuoka","year":"2013","unstructured":"Matsuoka H, Kuwajima I, Shimada K, Mitamura H, Saruta T. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study. J Clin Hypertens (Greenwich). 2013;15:806\u201314. https:\/\/doi.org\/10.1111\/jch.12208.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/joa3.13049","volume":"40","author":"AG Kim","year":"2024","unstructured":"Kim AG, Banga S, Ang QX, Atti L, Ghnaima H, AlAttal S, et al. Transdermal bisoprolol for prevention of postoperative atrial fibrillation: a systematic review and meta-analysis. J Arrhythm. 2024;40:434\u20139. https:\/\/doi.org\/10.1002\/joa3.13049.","journal-title":"J Arrhythm"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00540-016-2199-9","volume":"30","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Inokuchi R, Hiruma T, Tokunaga K, Doi K, Nakajima S. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia. J Anesth. 2016;30:891\u20134. https:\/\/doi.org\/10.1007\/s00540-016-2199-9.","journal-title":"J Anesth"},{"key":"924_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1121444","volume":"13","author":"CL Ge","year":"2023","unstructured":"Ge CL, Zhang LN, Ai YH, Chen W, Ye ZW, Zou Y, et al. Effect of \u03b2-blockers on mortality in patients with sepsis: a propensity-score matched analysis. Front Cell Infect Microbiol. 2023;13:1121444. https:\/\/doi.org\/10.3389\/fcimb.2023.1121444.","journal-title":"Front Cell Infect Microbiol"},{"key":"924_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000788","volume":"4","author":"B Liu","year":"2022","unstructured":"Liu B, Hadzi-Tosev M, Liu Y, et al. Accuracy of International Classification of Diseases. 10th revision codes for identifying sepsis: a systematic review and meta-analysis. Crit Care Explor. 2022;4:e0788. https:\/\/doi.org\/10.1097\/CCE.0000000000000788.","journal-title":"Crit Care Explor"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","volume":"61","author":"S Goradia","year":"2021","unstructured":"Goradia S, Sardaneh AA, Narayan SW, Penm J, Patanwala AE. Vasopressor dose equivalence: a scoping review and suggested formula. J Crit Care. 2021;61:233\u201340. https:\/\/doi.org\/10.1016\/j.jcrc.2020.11.002.","journal-title":"J Crit Care"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13613-024-01418-8","volume":"15","author":"X Si","year":"2025","unstructured":"Si X, Yuan H, Shi R, Song W, Guo J, Jiang J, et al. Comparison of the efficacy and safety of landiolol and esmolol in critically ill patients: a propensity score-matched study. Ann Intensive Care. 2025;15:5. https:\/\/doi.org\/10.1186\/s13613-024-01418-8.","journal-title":"Ann Intensive Care"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1253\/circj.CJ-19-0871","volume":"84","author":"H Toda","year":"2020","unstructured":"Toda H, Nakamura K, Shimizu K, Ejiri K, Iwano T, Miyoshi T, et al. Effects of bisoprolol transdermal patches for prevention of perioperative myocardial injury in high-risk patients undergoing non-cardiac surgery\u2014multicenter randomized controlled study. Circ J. 2020;84:642\u20139. https:\/\/doi.org\/10.1253\/circj.CJ-19-0871.","journal-title":"Circ J"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","volume":"159","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, et al. Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation. Chest. 2021;159:2289\u2013300. https:\/\/doi.org\/10.1016\/j.chest.2021.01.009.","journal-title":"Chest"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2023.20134","volume":"330","author":"T Whitehouse","year":"2023","unstructured":"Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, et al. Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA. 2023;330:1641\u201352. https:\/\/doi.org\/10.1001\/jama.2023.20134.","journal-title":"JAMA"},{"key":"924_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","volume":"167","author":"R Sato","year":"2025","unstructured":"Sato R, Messina S, Hasegawa D, Santonocito C, Scimonello G, Sanfilippo G, et al. Mortality in patients with sepsis treated with esmolol or landiolol. Chest. 2025;167:121\u201338. https:\/\/doi.org\/10.1016\/j.chest.2024.08.020.","journal-title":"Chest"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-026-00924-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:17:49Z","timestamp":1788340669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40560-026-00924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1186\/s40560-026-00924-0","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and the Japanese Clinical Trials Act (Act No. 16 of April 14, 2017). The protocol was approved by the Institutional Review Board for Clinical Research of Osaka General Medical Center (IRB No. 2022\u2013057). The board waived the requirement for informed consent because of the anonymous nature of the data and because no information on individual patients was obtained.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}